Stock listing
Frankfurt:TBH Teleflex Incorporated Aktie
German listing (Frankfurt) of Teleflex Incorporated · home listing NYSE:TFX
Follow Teleflex Incorporated into a list and get an email when it puts out news.
Share price · FWB:TBH
€147.30 EUR -3.50 (-2.3%)
Close on Nov 20, 2026
- Day range
- €147.30 – €147.30 EURNov 20, 2026
- Market cap
- €6.24B EURAt the close on Nov 20, 2026 · price × 42.37M shares outstanding
- 52-week range
- €84.75 – €147.30 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €1,461 EURMedian day 0 shares · 43 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:TFX · Home | $161.58 USD | -4.27 (-2.6%) | 654,988 | $164.07 | $166.52 | $161.47 | $165.85 | Close on Nov 20, 2026 |
| Frankfurt:TBH | €147.30 EUR | -3.50 (-2.3%) | — | €147.30 | €147.30 | €147.30 | €150.80 | Close on Nov 20, 2026 |
| B3:T1FX34 | 62.04 BRL | 0.00 (0.0%) | — | 62.04 | 62.04 | 62.04 | 62.04 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:TBH · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €135.43 | +3.744 | +2.8% | €135.43 | €135.43 | €135.43 | 0 | |
| €131.69 | +8.538 | +6.9% | €131.69 | €131.69 | €131.69 | 0 | |
| €123.15 | -1.59 | -1.3% | €123.15 | €123.15 | €123.15 | 0 | |
| €124.74 | +0.758 | +0.6% | €124.74 | €124.74 | €124.74 | 0 | |
| €123.98 | -0.83 | -0.7% | €123.98 | €123.98 | €123.98 | 0 | |
| €124.81 | +0.608 | +0.5% | €124.81 | €124.81 | €124.81 | 24 | |
| €124.20 | -0.384 | -0.3% | €124.20 | €124.20 | €124.20 | 0 | |
| €124.59 | +3.32 | +2.7% | €124.59 | €124.59 | €124.59 | 8 | |
| €121.27 | +1.307 | +1.1% | €121.27 | €121.27 | €121.27 | 0 | |
| €119.96 | -0.376 | -0.3% | €119.96 | €119.96 | €119.96 | 8 | |
| €120.34 | +1.036 | +0.9% | €120.34 | €120.34 | €120.34 | 0 | |
| €119.30 | +3.043 | +2.6% | €114.81 | €119.30 | €114.03 | 2 | |
| €116.26 | +2.142 | +1.9% | €116.26 | €116.26 | €116.26 | 0 | |
| €114.11 | -1.315 | -1.1% | €114.11 | €114.11 | €114.11 | 0 | |
| €115.43 | +2.447 | +2.2% | €115.43 | €115.43 | €115.43 | 0 | |
| €112.98 | +3.858 | +3.5% | €112.98 | €112.98 | €112.98 | 0 | |
| €109.12 | -0.959 | -0.9% | €109.12 | €109.12 | €109.12 | 0 | |
| €110.08 | -1.957 | -1.7% | €110.08 | €110.08 | €110.08 | 0 | |
| €112.04 | +0.406 | +0.4% | €112.04 | €112.04 | €112.04 | 0 | |
| €111.63 | +1.903 | +1.7% | €111.63 | €111.63 | €111.63 | 0 | |
| €109.73 | +0.30 | +0.3% | €109.73 | €109.73 | €109.73 | 68 | |
| €109.43 | 0.00 | 0.0% | €109.43 | €109.43 | €109.43 | 4 | |
| €109.43 | -2.098 | -1.9% | €109.43 | €109.43 | €109.43 | 0 | |
| €111.53 | +1.35 | +1.2% | €111.53 | €111.53 | €111.53 | 273 | |
| €110.18 | -1.613 | -1.4% | €110.18 | €110.18 | €110.18 | 0 | |
| €111.79 | +2.361 | +2.2% | €111.79 | €111.79 | €111.79 | 14 | |
| €109.43 | -1.363 | -1.2% | €109.43 | €109.43 | €109.43 | 0 | |
| €110.79 | -0.494 | -0.4% | €110.79 | €110.79 | €110.79 | 0 | |
| €111.29 | +5.696 | +5.4% | €111.29 | €111.29 | €111.29 | 0 | |
| €105.59 | +1.041 | +1.0% | €105.59 | €105.59 | €105.59 | 50 | |
| €104.55 | -1.625 | -1.5% | €104.55 | €104.55 | €104.55 | 0 | |
| €106.18 | -2.286 | -2.1% | €106.18 | €106.18 | €106.18 | 0 | |
| €108.46 | +0.629 | +0.6% | €108.46 | €108.46 | €108.46 | 0 | |
| €107.83 | -0.768 | -0.7% | €107.83 | €107.83 | €107.83 | 0 | |
| €108.60 | -0.132 | -0.1% | €108.60 | €108.60 | €108.60 | 0 | |
| €108.73 | -2.54 | -2.3% | €108.73 | €108.73 | €108.73 | 57 | |
| €111.27 | +0.637 | +0.6% | €111.77 | €112.02 | €110.70 | 57 | |
| €110.64 | -1.768 | -1.6% | €110.64 | €110.64 | €110.64 | 0 | |
| €112.40 | +1.336 | +1.2% | €112.40 | €112.40 | €112.40 | 0 | |
| €111.07 | -1.607 | -1.4% | €111.07 | €111.07 | €111.07 | 0 | |
| €112.68 | -2.591 | -2.2% | €112.68 | €112.68 | €112.68 | 0 | |
| €115.27 | -2.041 | -1.7% | €115.27 | €115.27 | €115.27 | 0 | |
| €117.31 | -0.589 | -0.5% | €117.31 | €117.31 | €117.31 | 0 | |
| €117.90 | -0.351 | -0.3% | €117.90 | €117.90 | €117.90 | 22 | |
| €118.25 | -1.059 | -0.9% | €118.25 | €118.25 | €118.25 | 0 | |
| €119.31 | -1.758 | -1.5% | €119.31 | €119.31 | €119.31 | 22 | |
| €121.06 | +0.797 | +0.7% | €121.06 | €121.06 | €121.06 | 0 | |
| €120.27 | -1.434 | -1.2% | €120.27 | €120.27 | €120.27 | 0 | |
| €121.70 | +2.171 | +1.8% | €121.70 | €121.70 | €121.70 | 0 | |
| €119.53 | +3.213 | +2.8% | €119.53 | €119.53 | €119.53 | 0 | |
| €116.32 | -2.399 | -2.0% | €116.32 | €116.32 | €116.32 | 130 | |
| €118.72 | -1.495 | -1.2% | €118.72 | €118.72 | €118.72 | 0 | |
| €120.21 | +2.165 | +1.8% | €120.21 | €120.21 | €120.21 | 0 | |
| €118.05 | +0.462 | +0.4% | €118.05 | €118.05 | €118.05 | 0 | |
| €117.58 | +2.952 | +2.6% | €117.58 | €117.58 | €117.58 | 0 | |
| €114.63 | -0.474 | -0.4% | €114.63 | €114.63 | €114.63 | 0 | |
| €115.11 | +2.456 | +2.2% | €115.11 | €115.11 | €115.11 | 0 |
- Ticker
- Frankfurt:TBH
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 11, 2026
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Latest earnings call · Nov 5, 2026
Teleflex (NYSE:TFX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 37 slides
Latest news
Q3 (Q3 2026 Earnings Call Presentation FINAL)
Nov 5, 2026
Closed €131.69 (+6.9%) on Nov 5, 2026
Q3 2026 Teleflex Incorporated Earnings Call Presentation
Nov 5, 2026
Closed €131.69 (+6.9%) on Nov 5, 2026
Teleflex Announces Quarterly Dividend
Nov 5, 2026
Closed €131.69 (+6.9%) on Nov 5, 2026
Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
Nov 5, 2026
Closed €131.69 (+6.9%) on Nov 5, 2026
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Oct 22, 2026
Closed €119.30 (+2.6%) on Oct 22, 2026
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Oct 22, 2026
Closed €119.30 (+2.6%) on Oct 22, 2026
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Oct 12, 2026
Closed €111.63 (+1.7%) on Oct 12, 2026
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
Sep 29, 2026
Closed €111.29 (+5.4%) on Sep 29, 2026
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
Sep 8, 2026
Closed €117.90 (-0.3%) on Sep 8, 2026
Teleflex Incorporated on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 34 in the last 12 months · 62 in all · newest Nov 11, 2026 · oldest 2025
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 129 decks · latest Nov 5, 2026
Where Teleflex Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:TFX · Home listing | NYSE | United States | USD |
| gettex:TBH | gettex | Germany | EUR |
| BMV:TFX | BMV | Mexico | MXN |
| LS Exchange:855853 | LS Exchange | Germany | EUR |
| Lang & Schwarz:855853 | Lang & Schwarz | Germany | EUR |
| Frankfurt:TBH · This page | Frankfurt | Germany | EUR |
| B3:T1FX34 | B3 | Brazil | BRL |
| BX Swiss:TBH | BX Swiss | Switzerland | CHF |
| Milan:1TFX | Milan | Italy | EUR |
| BOATS:TFX | BOATS | United States | USD |
| Tradegate:TBH | Tradegate | Germany | EUR |
| BIVA:TFX | BIVA | Mexico | MXN |
| Dusseldorf:TBH | Dusseldorf | Germany | EUR |
| Hanover:TBH | Hanover | Germany | EUR |
| LSE:0ADI | LSE | United Kingdom | USD |
| Munich:TBH | Munich | Germany | EUR |
| Stuttgart:TBH | Stuttgart | Germany | EUR |
Valuation
P/E 22.5× against a median of 28.6×: 3rd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $8.04B USD
- P/E
- 22.5×
- EV/sales
- 3.6×
- EV/EBITDA
- 20.1×
- Price/book
- 2.0×
- Gross margin
- 58.3%
- Operating margin
- 9.4%
- Net margin
- 13.5%
- Debt to equity
- 0.5×
- Beta vs S&P 500
- 0.50
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Teleflex Incorporated · NYSE:TFX | US$6.85B | US$8.04B | 22.5× | 3.6× | 20.1× | 2.0× | 13.5% | 0.5× | 0.50 |
| Insulet Corporation · NASDAQ:PODD | US$9.24B | US$9.62B | 21.5× | 3.0× | 13.9× | 5.8× | 13.5% | 0.6× | 0.53 |
| Globus Medical, Inc. · NYSE:GMED | US$7.48B | US$7.07B | 13.4× | 2.3× | 7.4× | 1.6× | 17.8% | 0.0× | 0.89 |
| Getinge AB Class B · OMXSTO:GETI_B | US$6.89B | US$7.68B | 24.9× | 2.3× | 11.2× | 2.1× | 8.2% | 0.3× | n/a |
| Ypsomed Holding AG · SIX:YPSN | US$6.80B | US$6.76B | 25.7× | 7.8× | 17.3× | 7.2× | 30.4% | 0.0× | n/a |
| ConvaTec Group PLC · LSE:CTEC | US$6.64B | US$8.29B | 37.9× | 3.4× | 15.2× | 4.6× | 7.2% | 1.2× | n/a |
| Cochlear Limited · ASX:COH | US$6.49B | US$6.51B | 66.6× | 4.2× | 24.2× | 5.6× | 6.3% | 0.1× | n/a |
| APT Medical Inc. Class A · SSE:688617 | US$6.00B | US$5.73B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| Median of the others | US$6.57B | US$6.63B | 28.6× | 3.3× | 15.4× | 5.1× | 11.5% | 0.3× | 0.53 |
Forecasts
2 strong buy · 4 buy · 6 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 168.09 USD · Analysts' mean
- EPS, year to Dec 2026
- 7.68 · 12 analysts
- Revenue, year to Dec 2026
- 2.26B · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jason Weidman | President and CEO |
| John Deren | Executive Vice President and Chief Financial Officer |
| Jake Newman | President and General Manager, Vascular and Emergency Medicine |
| James Ferguson | President and General Manager, Surgical |
| Kevin Robinson | President and General Manager, Anesthesia & Emergency Medicine |
| Travis Gay | President and General Manager, Interventional Urology |
| Daniel V. Logue | Corporate Vice President, General Counsel and Secretary |
| Lawrence Keusch | Vice President of Investor Relations and Strategy Development |
| Bert Lane | Vice President, Global Logistics and Distribution |
| Cameron Hicks | Corporate Vice President and Chief Human Resources Officer |
| Daniel Price | Corporate Vice President, Commercial Finance |
| Dominik Reterski | Corporate Vice President, Quality Assurance/Regulatory Affairs |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| James Winters | Corporate Vice President, Manufacturing & Supply Chain |
| Marie Hendrixson | Vice President, Internal Audit |
| Matt Tomkin | Corporate Vice President, Business Development |
| Matthew Howald | Vice President, Treasurer |
| Timothy Duffy | Vice President and Chief Information Officer |
| Whitney Reynolds | Vice President, Global Customer Experience |
| Sean M. Salmon | Executive |
Board
| Director | Role |
|---|---|
| Andrew A. Krakauer | Chairman of the Board |
Events
Calls
| Call | When | Status |
|---|---|---|
| Teleflex (NYSE:TFX) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2026 Earnings Call | Thu, Aug 06, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q1 2026 Earnings Call | Thu, May 07, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2025 Earnings Call | Thu, Jul 31, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q1 2025 Earnings Call | Thu, May 01, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q3 2024 Earnings Call | Thu, Oct 31, 2024 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 8:00 AM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +1.5% |
| Q2 2026 | Aug 6, 2026 · Before open | +1.5% |
| Q1 2026 | May 7, 2026 · Before open | +6.9% |
| Q4 2025 | Feb 26, 2026 | +9.1% |
| Q3 2025 | Nov 6, 2025 · Before open | −13.0% |
| Q2 2025 | Jul 31, 2025 · Before open | +4.9% |
| Q1 2025 | Apr 30, 2025 · Before open | −0.8% |
| Q4 2024 | Feb 27, 2025 · Before open | −21.7% |
| Q3 2024 | Oct 31, 2024 · Before open | −14.5% |
| Q2 2024 | Aug 1, 2024 · Before open | +6.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · Before open | −6.1% |
| Q4 2023 | Feb 22, 2024 · Before open | −5.3% |
| Q3 2023 | Nov 2, 2023 · Before open | +11.6% |
| Q2 2023 | Aug 3, 2023 · Before open | −3.7% |
| Q1 2023 | May 4, 2023 · Before open | −8.5% |
| Q4 2022 | Feb 23, 2023 · Before open | −2.1% |
| Q3 2022 | Oct 27, 2022 · Before open | +1.6% |
| Q2 2022 | Jul 28, 2022 · Before open | −7.8% |
| Q1 2022 | Apr 28, 2022 · Before open | −6.5% |
| Q4 2021 | Feb 24, 2022 · Before open | +4.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 37 slides | Nov 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 35 slides | Aug 6, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 28 slides | May 7, 2026 |
| FY2025 Earnings Presentation | Earnings | 36 slides | Feb 26, 2026 |
| Investor Day (November 2025) | Investor day | 19 slides | Nov 14, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 34 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 33 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | May 1, 2025 |
| Merger or Acquisition (February 2025) | Merger or acquisition | 26 slides | Feb 27, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 28 slides | Feb 27, 2025 |
Show 50 decks
This page holds 50 of 129 decks. Open Decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.99B | 1.70B | 1.71B | 2.79B | 2.81B | 2.54B | 2.60B | 2.45B | 2.15B | 1.87B |
| Cost of revenue | 872.0M | 662.2M | 672.3M | 1.26B | 1.26B | 1.21B | 1.19B | 1.15B | 974.5M | 871.8M |
| Gross profit | 1.12B | 1.04B | 1.04B | 1.53B | 1.55B | 1.32B | 1.41B | 1.30B | 1.17B | 996.2M |
| Research and development | 144.8M | 109.0M | 113.6M | 153.8M | 130.8M | 119.7M | 113.9M | 106.2M | 84.8M | 58.6M |
| Selling, general and administrative | 720.2M | 674.5M | 622.7M | 863.7M | 860.1M | 743.6M | 851.8M | 797.1M | 700.0M | 563.3M |
| Operating income | 118.4M | 103.7M | 258.7M | 499.7M | 628.1M | 423.1M | 427.3M | 321.7M | 372.3M | 319.5M |
| Depreciation and amortization | 177.7M | 161.5M | 148.1M | 230.6M | 237.4M | 227.3M | 218.4M | 214.7M | 160.3M | 128.3M |
| EBITDA | 296.1M | 265.2M | 406.8M | 730.3M | 865.5M | 650.3M | 645.6M | 536.4M | 532.6M | 447.8M |
| Interest expense | 100.2M | 83.5M | 85.1M | 54.3M | 57.0M | 66.5M | 80.3M | 103.0M | 82.5M | 54.9M |
| Income before tax | 24.6M | 26.3M | 185.4M | 445.9M | 559.5M | 357.7M | 339.9M | 219.6M | 284.9M | 245.7M |
| Income tax | -34.0M | -30.9M | 41.9M | 83.0M | 74.3M | 21.9M | -122.1M | 23.2M | 129.6M | 8.07M |
| Net income | -905.6M | 69.7M | 356.3M | 363.1M | 485.4M | 335.3M | 461.5M | 200.8M | 152.5M | 237.4M |
| Earnings per share, basic | -20.30 | 1.49 | 7.58 | 7.74 | 10.38 | 7.21 | 9.99 | 4.39 | 3.39 | 5.48 |
| Earnings per share, diluted | -20.25 | 1.48 | 7.53 | 7.68 | 10.23 | 7.09 | 9.80 | 4.29 | 3.27 | 4.98 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 378.6M | 247.9M | 222.8M | 292.0M | 445.1M | 375.9M | 301.1M | 357.2M | 333.6M | 543.8M |
| Short-term investments | 16.0M | 16.9M | 48.5M | 21.7M | 20.1M | 21.6M | 14.7M | 0 | 0 | |
| Receivables | 345.6M | 226.7M | 443.5M | 408.8M | 383.6M | 395.1M | 418.7M | 366.3M | 345.9M | 272.0M |
| Inventory | 404.4M | 306.8M | 626.2M | 578.5M | 477.6M | 513.2M | 476.6M | 427.8M | 395.7M | 316.2M |
| Current assets | 1.94B | 1.47B | 1.41B | 1.41B | 1.43B | 1.42B | 1.31B | 1.24B | 1.13B | 1.18B |
| Property, plant and equipment | 498.3M | 308.5M | 479.9M | 447.2M | 443.8M | 473.9M | 430.7M | 432.8M | 383.0M | 302.9M |
| Goodwill | 2.31B | 1.99B | 2.91B | 2.54B | 2.50B | 2.59B | 2.25B | 2.25B | 2.24B | 1.28B |
| Total assets | 6.95B | 7.10B | 7.53B | 6.93B | 6.87B | 7.15B | 6.31B | 6.28B | 6.18B | 3.89B |
| Accounts payable | 130.2M | 97.9M | 132.2M | 126.8M | 118.2M | 102.5M | 102.9M | 106.7M | 92.0M | 69.4M |
| Current liabilities | 762.0M | 649.4M | 606.7M | 581.5M | 680.1M | 540.0M | 563.1M | 582.5M | 483.9M | 427.6M |
| Long-term debt | 2.54B | 1.56B | 1.73B | 1.62B | 1.74B | 2.38B | 1.86B | 2.07B | 2.16B | 850.3M |
| Total debt | 2.64B | 1.66B | 1.82B | 1.71B | 1.85B | 2.48B | 1.91B | 2.16B | 2.25B | 1.03B |
| Total liabilities | 3.82B | 2.82B | 3.09B | 2.91B | 3.12B | 3.82B | 3.33B | 3.74B | 3.75B | 1.75B |
| Shareholders' equity | 3.12B | 4.28B | 4.44B | 4.02B | 3.75B | 3.34B | 2.98B | 2.54B | 2.43B | 2.14B |
| Shares outstanding | 39.7M | 39.7M | 44.2M | 44.2M | 46.4M | 47.1M | 46.9M | 46.9M | 46.7M | 46.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 96.7M | 301.9M | 206.1M | 342.8M | 652.1M | 437.1M | 437.1M | 435.1M | 426.3M | 410.6M |
| Capital spending | -95.2M | -90.4M | -46.4M | -79.2M | -71.6M | -90.7M | -102.7M | -80.8M | -70.9M | -53.1M |
| Free cash flow | 1.45M | 211.4M | 159.7M | 263.6M | 580.5M | 346.4M | 334.4M | 354.3M | 355.4M | 357.5M |
| Cash from investing | -812.7M | -63.4M | 27.3M | -259.4M | 156.7M | -837.8M | -73.5M | -196.4M | -1.83B | -57.0M |
| Cash from financing | 611.5M | -421.9M | 38.5M | -217.5M | -715.8M | 455.2M | -418.8M | -206.4M | 1.14B | -118.7M |
| Dividends paid | -60.3M | -63.5M | -63.9M | -63.8M | -63.6M | -63.2M | -62.8M | -62.2M | -61.2M | -59.0M |
| Share buybacks | -300.0M | -200.0M | 0 | 0 | 412.5M | 19.0M | 21.2M | 22.7M | 5.57M | 9.07M |
| Change in cash | 126.2M | 104.8M | -69.2M | -153.1M | 69.2M | 74.8M | -56.1M | 23.6M | -210.2M | 205.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 8, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 8, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
| 8-K/A · Current report, amended | Aug 5, 2026 | Current report | SEC |
| 8-K · Current report | Aug 3, 2026 | Acquisition or disposal | SEC |
| 11-K · Annual report of an employee plan | Jun 26, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 15, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 9, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| SD · Specialized disclosure | May 28, 2026 | ESG report | SEC |
| 8-K · Current report | May 27, 2026 | Material contract | SEC |
| 8-K · Current report | May 20, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| 8-K · Current report | Apr 30, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 13, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 13, 2026 | Meeting notice | SEC |
| 8-K · Current report | Mar 27, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 17, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 11, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 23, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2026 | Results | SEC |
| 8-K · Current report | Dec 9, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 17, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 31, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Results | SEC |
| 8-K · Current report | Jun 27, 2025 | Material contract | SEC |
| 11-K · Annual report of an employee plan | Jun 27, 2025 | Annual report | SEC |
| SD · Specialized disclosure | May 29, 2025 | ESG report | SEC |
| 8-K · Current report | May 15, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 1, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 3, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Mar 28, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 28, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 28, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 3, 2025 | Current report | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2025 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 7, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 31, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 31, 2024 | Results | SEC |
| 8-K · Current report | Aug 29, 2024 | Current report | SEC |
| 4 · Change in ownership | Aug 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 16, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 16, 2024 | Other filings | SEC |
| 8-K · Current report | Aug 5, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 2, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2024 | Results | SEC |
| 11-K · Annual report of an employee plan | Jun 28, 2024 | Annual report | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 8-K · Current report | May 9, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | May 3, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 5, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 1, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 1, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 10-K · Annual report | Feb 23, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 22, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 8, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 24, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 27, 2023 | Other filings | SEC |
| 4 · Change in ownership | Dec 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2023 | Insider trade | SEC |
| SC 13G · Big-stake notice | Dec 7, 2023 | Big-stake notice | SEC |
This page holds 200 of 1,008 filings. Open Filings
Cap table
Built by 6ix from Teleflex Incorporated’s releases
- Common shares
- 42,372,397
- Fully diluted
- 42,372,397
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 42,372,397 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 42,372,397 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard A Meier Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Dec 14, 2006); Rockley Photonics Holdings Ltd (President & CFO · Oct 20, 2022 – Oct 21, 2022 · Past); Intersect ENT Inc (EVP & Chief Financial Officer · Nov 26, 2019 – May 13, 2022 · Past); Accendra Health, Inc. (EVP, Chief Financial Officer · Mar 1, 2013 – Feb 8, 2018 · Past); STAAR Surgical Company (Director · Jun 25, 2009 – May 19, 2016 · Past); Advanced Medical Optics Inc (President and COO · May 24, 2006 – Aug 6, 2008 · Past) | Exec. Vice Pres. and CFO · Jan 11, 2010 – Feb 28, 2012 · Past |
| Kevin Gordon Other companies: Progyny, Inc. (Director · Since at least Oct 24, 2019); Veracyte, Inc. (Director · Dec 12, 2016 – Jun 8, 2022 · Past); IQVIA Holdings, Inc. (EVP and COO · May 8, 2013 – Jun 9, 2016 · Past) | Exec. Vice Pres. & CFO · Dec 25, 2005 – Dec 31, 2009 · Past |
| W Kim Foster Other companies: Hexcel Corporation (Director · May 10, 2007 – Jul 6, 2018 · Past); JLG Industries Inc (Director · Dec 6, 2006 – Dec 6, 2006 · Past); FMC Corporation (Executive VP and CFO · Feb 23, 2006 – Mar 2, 2012 · Past) | Director · May 3, 2013 – May 16, 2018 · Past |
| Benson Smith Other companies: Zoll Medical Corp (Director · Nov 14, 2006 – Apr 26, 2012 · Past); Rochester Medical Corporation (Director · Jan 26, 2006 – Dec 26, 2012 · Past) | Director · Feb 22, 2006 – Feb 18, 2020 · Past |
| Candace H Duncan Other companies: FTD Companies Inc (Director · Jun 5, 2018 – Jun 5, 2018 · Past); Discover Financial Services (Director · May 2, 2018 – May 15, 2025 · Past) | Director · Since at least May 16, 2018 |
| Gretchen Haggerty Other companies: Atmus Filtration Technologies Inc. (Director · Since at least May 14, 2024); Johnson Controls International plc (Director · Since at least Mar 9, 2024) | Director · Since at least May 7, 2024 |
| Michael J. Tokich Other companies: Mettler-Toledo International, Inc. (Director · Since at least Jan 20, 2026); STERIS plc (Ireland) (Sr. Vice Pres., CFO · Since at least Apr 7, 2022) | Director · Since at least May 15, 2026 |
| Patricia C Barron Other companies: Ultralife Corporation (Director · Nov 19, 2008 – Nov 15, 2012 · Past); Quaker Houghton (Director · Oct 1, 2008 – Aug 10, 2015 · Past) | Director · Nov 21, 2008 – Feb 23, 2017 · Past |
| Sean Salmon Other companies: Adagio Medical Holdings, Inc (Director · Since at least Dec 11, 2025); Medtronic plc. (EVP & President Cardiovascular · Nov 1, 2019 – Dec 16, 2024 · Past) | Executive · Since at least Sep 8, 2026 |
| Stephen Klasko Other companies: DocGo Inc. (Director · Since at least Oct 1, 2024); Health Assurance Acquisition Corp (Director · Nov 12, 2020 – Nov 12, 2020 · Past) | Chairman of the Board · Oct 2, 2017 – Nov 5, 2026 · Past |
All 47 people
| Person | Seat |
|---|---|
| Stuart Randle Other companies: Decoy Therapeutics Inc. (Director · Jan 28, 2015 – Jul 25, 2018 · Past); Beacon Roofing Supply Inc (Director · Feb 15, 2006 – May 23, 2024 · Past) | Director · Since at least May 1, 2009 |
| Andrew A. Krakauer Other companies: Cantel Medical Corp (CEO, Director · Oct 13, 2006 – Dec 28, 2015 · Past) | Chairman of the Board · Since at least Jan 1, 2018 |
| Charles Edward Williams Other companies: IQVIA Holdings, Inc. (Sr VP and Controller · May 8, 2013 – Mar 3, 2017 · Past) | Corp. Controller and CAO · Sep 19, 2006 – Mar 4, 2011 · Past |
| Clark D Handy Other companies: Convergys Corporation (SVP Human Resources · Dec 11, 2006 – Jun 18, 2010 · Past) | Exec.Vice Pres. · Dec 25, 2005 – Nov 16, 2006 · Past |
| Jaewon Ryu Other companies: Privia Health Group, Inc. (Director · Since at least Jun 30, 2021) | Director · Since at least May 5, 2023 |
| John C Heinmiller Other companies: St. Jude Medical Inc (Executive Vice President · Dec 12, 2006 – Jan 4, 2017 · Past) | Director · Jan 1, 2019 – May 9, 2025 · Past |
| Liam J. Kelly Other companies: Enovis Corporation (Director · Since at least Jan 1, 2020) | Chairman, President & CEO, Director · Since at least Feb 26, 2014 |
| Neena M Patil Other companies: Jazz Pharmaceuticals plc (EVP & Chief Legal Officer · Since at least Jul 29, 2019) | Director · Since at least Apr 29, 2022 |
| Richard A Packer Other companies: Bruker Corporation (Director · Since at least Dec 16, 2019) | Director · May 7, 2019 – May 4, 2021 · Past |
| William Roland Cook Other companies: Quaker Houghton (Director · Jun 1, 2006 – Nov 20, 2017 · Past) | Director · Feb 22, 2006 – Aug 12, 2016 · Past |
| Bert Lane | Vice President, Global Logistics and Distribution · Since at least Nov 5, 2026 |
| Cameron Hicks | Corporate Vice President and Chief Human Resources Officer · Since at least Dec 8, 2014 |
| Daniel Price | Corporate Vice President, Commercial Finance · Since at least Nov 5, 2026 |
| Daniel V. Logue | Corporate Vice President, General Counsel and Secretary · Since at least Feb 23, 2026 |
| Dominik Reterski | Corporate Vice President, Quality Assurance/Regulatory Affairs · Since at least Apr 1, 2026 |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer · Since at least Nov 5, 2026 |
| Jake Newman | President and General Manager, Vascular and Emergency Medicine · Since at least Sep 29, 2026 |
| James Ferguson | President and General Manager, Surgical · Since at least May 13, 2025 |
| James Winters | Corporate Vice President, Manufacturing & Supply Chain · Since at least Feb 18, 2020 |
| Jason Weidman | President and CEO · Since at least Apr 30, 2026 |
| Jay White | CVP & Pres, Global Commercial · Feb 23, 2021 – Mar 4, 2025 · Past |
| John Deren | Executive Vice President and Chief Financial Officer · Since at least Feb 23, 2018 |
| Julie McDowell | Sr. VP Corp. Communic. · Feb 26, 2008 – Mar 4, 2008 · Past |
| Kevin Robinson | President and General Manager, Anesthesia & Emergency Medicine · Since at least Apr 30, 2025 |
| Laurence G Miller | EVP, Chf Admin Off, GC & Sec'y · Dec 25, 2005 – Mar 18, 2013 · Past |
| Lawrence Keusch | Vice President of Investor Relations and Strategy Development · Since at least Sep 4, 2026 |
| Marie Hendrixson | Vice President, Internal Audit · Since at least Nov 5, 2026 |
| Mario Wijker | Vice President, QARA · Feb 18, 2020 – Feb 25, 2020 · Past |
| Matthew Howald | Vice President, Treasurer · Since at least Nov 5, 2026 |
| Matt Tomkin | Corporate Vice President, Business Development · Since at least Nov 5, 2026 |
| Sigismundus W W Lubsen | Director · Feb 22, 2006 – Mar 16, 2015 · Past |
| Teleflex Lawrence Keusch | Vice President, Investor Relations and Strategy Development · Sep 11, 2025 – Nov 4, 2026 · Past |
| Thomas E Powell | Executive Vice President & CFO · Feb 23, 2018 – Apr 1, 2025 · Past |
| Timothy Duffy | Vice President and Chief Information Officer · Since at least Nov 5, 2026 |
| Travis Gay | President and General Manager, Interventional Urology · Since at least May 21, 2026 |
| Vincent Northfield | Exec. VP - Global Ops-Medical · Dec 12, 2005 – Mar 8, 2011 · Past |
| Whitney Reynolds | Vice President, Global Customer Experience · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Teleflex Incorporated.